ALLIENT INC·4

Mar 9, 7:59 PM ET

WARZALA RICHARD S 4

4 · ALLIENT INC · Filed Mar 9, 2026

Research Summary

AI-generated summary of this filing

Updated

ALLIENT (ALNT) CEO Warzala Receives $2.37M in Restricted Shares

What Happened
Richard S. Warzala, CEO of ALLIENT INC (ALNT), was granted a total of 38,176 restricted shares on 2026-03-05 (three separate awards) at a reported price of $62.07 per share, with an aggregate reported value of $2,369,585. These transactions are classified as awards/grants (Form 4 code "A") — not open-market purchases or sales — meaning Warzala acquired these shares subject to vesting and/or performance conditions.

Key Details

  • Transaction date and price: 2026-03-05 at $62.07 per share.
    • 18,850 shares — $1,170,020 (time‑based restricted shares) (Footnote F1).
    • 15,709 shares — $975,058 (performance‑based restricted shares) (Footnote F2).
    • 3,617 shares — $224,507 (performance‑based restricted shares earned for 2025) (Footnote F3).
  • Total: 38,176 shares; total reported value $2,369,585.
  • Vesting/conditions:
    • F1 (time‑based): vests one‑third on April 1 of 2027, 2028, and 2029.
    • F2 (performance‑based): may vest over three years upon satisfaction of performance goals set for the year ending 12/31/2026.
    • F3 (performance‑based earned): satisfied for 2025 and vests one‑third on April 1 of 2026, 2027, and 2028.
  • Shares owned after the reported transactions: not stated in the provided filing details.
  • Filing: Form 4 filed 2026-03-09 reporting activity on 2026-03-05 — filing appears to be timely.

Context
These are equity compensation awards (restricted shares) common for executives and are different from purchases or sales: time‑based awards vest over future dates and performance awards only vest if specific targets are met. Because many shares are subject to vesting and performance conditions, they do not represent immediate liquid ownership or a direct market purchase signal.

Insider Transaction Report

Form 4
Period: 2026-03-05
WARZALA RICHARD S
DirectorChief Executive Officer
Transactions
  • Award

    Common Stock

    [F1]
    2026-03-05$62.07/sh+18,850$1,170,0201,572,736 total
  • Award

    Common Stock

    [F2]
    2026-03-05$62.07/sh+15,709$975,0581,588,445 total
  • Award

    Common Stock

    [F3]
    2026-03-05$62.07/sh+3,617$224,5071,592,062 total
Holdings
  • Common Stock

    (indirect: By Trust)
    26,067
Footnotes (3)
  • [F1]Grant of time-based restricted shares pursuant to the Company's 2017 Omnibus Incentive Plan. These restricted shares vest one-third each on April 1, 2027, 2028 and 2029.
  • [F2]Grant of performance-based restricted shares pursuant to the Company's 2017 Omnibus Incentive Plan. All or a portion of these restricted shares will vest over a three-year period upon the satisfaction of certain performance goals established by the Compensation Committee for the year ending December 31, 2026.
  • [F3]Grant of performance-based restricted shares pursuant to the Company's 2017 Omnibus Incentive Plan. These restricted shares were earned upon the satisfaction of certain performance goals established by the Compensation Committee for the year ended December 31, 2025 and vest one-third each on April 1, 2026, 2027 and 2028.
Signature
/s/ Michael C. Donlon, Attorney-in-Fact for Richard S. Warzala|2026-03-09

Documents

1 file
  • 4
    form4.xmlPrimary

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES